Koneksa Announces Partnership with Beacon Biosignals for Clinical Trial in Sleep and Neurologic Disorders Using EEG Biomarkers
Digital Health Global
JUNE 13, 2023
NEW YORK–(BUSINESS WIRE)– #biotech — Kone k sa , the evidence-based digital biomarkers company, announced today a partnership with Beacon Biosignals , the leading computational neurodiagnostics company, to launch a clinical trial to investigate the integration of Beacon’s at-home electroencephalogram (EEG) into the Koneksa Neuroscience (..)
Let's personalize your content